Protective effect of quercetin in primary neurons against Aβ(1-42): relevance to Alzheimer's disease

Journal of Nutritional Biochemistry

Volumn 20, Issue 4, 2009, Pages 269-275

  Ansari, Mubeen Ahmad ^a,b   Abdul, Hafiz Mohammad ^a   Joshi, Gururaj ^a   Opii, Wycliffe O ^a   Butterfield, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

A (1 42); Alzheimer's disease; Neuroprotection; Oxidative stress; Quercetin

Indexed keywords

3 NITROTYROSINE; AMYLOID BETA PROTEIN[1-42]; QUERCETIN;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FETUS; HIPPOCAMPUS; LIPID PEROXIDATION; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL DEATH; CELLS, CULTURED; FLUORESCEINS; HIPPOCAMPUS; LIPID PEROXIDATION; NEURONS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 61749103704     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2008.03.002     Document Type: Article

References (52)

1. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine (1999), Oxford University Press, Oxford
2. Butterfield D.A., et al. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 43 5 (2007) 658-677
3. Fahn S., and Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32 6 (1992) 804-812
4. Mecocci P., MacGarvey U., and Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36 5 (1994) 747-751
5. Greenamyre J.T., Betarbet R., and Sherer T.B. The rotenone model of Parkinson's disease: genes, environment and mitochondria. Parkinsonism Relat Disord 9 Suppl 2 (2003) S59-S64
6. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23 1 (1997) 134-147
7. Multhaup G., et al. Reactive oxygen species and Alzheimer's disease. Biochem Pharmacol 54 5 (1997) 533-539
8. Gao Z., Huang K., and Xu H. Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. Pharmacol Res 43 2 (2001) 173-178
9. Mercer L.D., et al. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem Pharmacol 69 2 (2005) 339-345
10. Youdim K.A., and Joseph J.A. A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Radic Biol Med 30 6 (2001) 583-594
11. Paganga G., Miller N., and Rice-Evans C.A. The polyphenolic content of fruit and vegetables and their antioxidant activities. What does a serving constitute?. Free Radic Res 30 2 (1999) 153-162
12. Duarte J., et al. Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur J Pharmacol 239 1-3 (1993) 1-7
13. Brown J.P. A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Mutat Res 75 3 (1980) 243-277
14. Rice-Evans C.A., et al. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res 22 4 (1995) 375-383
15. Heo H.J., and Lee C.Y. Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration. J Agric Food Chem 52 25 (2004) 7514-7517
16. Bate C., Salmona M., and Williams A. Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42. J Neuroinflammation 1 1 (2004) 4
17. Yagyu K., et al. Protective effects of estradiol against amyloid beta protein-induced inhibition of neuronal Cl(-)-ATPase activity. Neuropharmacology 43 8 (2002) 1297-1304
18. Schroeter H., et al. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 358 Pt 3 (2001) 547-557
19. Patil C.S., et al. Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice. Pharmacology 69 2 (2003) 59-67
20. Sultana R., et al. Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J Neurochem 92 4 (2005) 749-758
21. Butterfield D.A., and Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 32 11 (2002) 1050-1060
22. Butterfield D.A., et al. Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease. Methods Enzymol 309 (1999) 746-768
23. Butterfield D.A. beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem Res Toxicol 10 5 (1997) 495-506
24. Lauderback C.M., et al. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem 78 2 (2001) 413-416
25. Ahmad M., et al. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem 93 1 (2005) 94-104
26. Ursini F. In: Paoletti R. (Ed). Thoughts on physiological functions from enzymology and molecular structure in oxidative processes and antioxidants (1994), Raven, New York 25-31
27. Bains J.S., and Shaw C.A. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev 25 3 (1997) 335-358
28. Benzi G., and Moretti A. Are reactive oxygen species involved in Alzheimer's disease?. Neurobiol Aging 16 4 (1995) 661-674
29. Anderson M.E., and Luo J.L. Glutathione therapy: from prodrugs to genes. Semin Liver Dis 18 4 (1998) 415-424
30. Drake J., et al. Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. J Neurosci Res 68 6 (2002) 776-784
31. Pocernich C.B., La Fontaine M., and Butterfield D.A. In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochem Int 36 3 (2000) 185-191
32. LeWitt P.A. New drugs for the treatment of Parkinson's disease. Pharmacotherapy 20 1 Pt 2 (2000) 26S-32S
33. Edwin Shackelford R., et al. Pharmacological manipulation of ataxia-telangiectasia kinase activity as a treatment for Parkinson's disease. Med Hypotheses 64 4 (2005) 736-741
34. Marchbanks R.M., et al. A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr Res 65 1 (2003) 33-38
35. Eberhardt M.V., Lee C.Y., and Liu R.H. Antioxidant activity of fresh apples. Nature 405 6789 (2000) 903-904
36. Kim H., et al. Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem 53 22 (2005) 8537-8541
37. Prasad M.R., et al. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 23 1 (1998) 81-88
38. Ishige K., Schubert D., and Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 30 4 (2001) 433-446
39. Naidu P.S., Singh A., and Kulkarni S.K. Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia. Neuropharmacology 44 8 (2003) 1100-1106
40. Bastianetto S., and Quirion R. Natural extracts as possible protective agents of brain aging. Neurobiol Aging 23 5 (2002) 891-897
41. Youdim K.A., et al. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 36 5 (2004) 592-604
42. Sanders R.A., Rauscher F.M., and Watkins III J.B. Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 15 3 (2001) 143-149
43. Singh A., Naidu P.S., and Kulkarni S.K. Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin a bioflavonoid. Free Radic Res 37 11 (2003) 1245-1252
44. Juurlink B.H., and Paterson P.G. Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med 21 4 (1998) 309-334
45. Gosslau A., and Rensing L. Induction of Hsp68 by oxidative stress involves the lipoxygenase pathway in C6 rat glioma cells. Brain Res 864 1 (2000) 114-123
46. O'Brien P.J. In: Chow C.K. (Ed). Cellular antioxidant defense mechanism vol 1 (1988), CRC, Boca Raton, FL 73-87
47. Lovell M.A., Xie C., and Markesbery W.R. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51 6 (1998) 1562-1566
48. Mark R.J., et al. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem 68 1 (1997) 255-264
49. Koppal T., Drake J., and Butterfield D.A. In vivo modulation of rodent glutathione and its role in peroxynitrite-induced neocortical synaptosomal membrane protein damage. Biochim Biophys Acta 1453 3 (1999) 407-411
50. Pocernich C.B., and Butterfield D.A. Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox Res 5 7 (2003) 515-520
51. Ramachandran V., et al. Ethanol-induced oxidative stress precedes mitochondrially mediated apoptotic death of cultured fetal cortical neurons. J Neurosci Res 74 4 (2003) 577-588
52. Boyd-Kimball D., et al. Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. Chem Res Toxicol 17 12 (2004) 1743-1749